Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Filament Health Corp. Filament Health Announces First Dosing in Groundbreaking FDA-Approved Psilocin Clinical Trial July 07, 2022 From Filament Health Corp. Via Business Wire Tickers FLHLF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
